Company profile
Percheron Therapeutics Limited
We are dedicated to developing and commercializing treatments for patients and families devastated by rare diseases.
- Industry
- Biotechnology Research
- Employees
- 9
- Headquarters
- Melbourne, Victoria
- Founded
- 2000
- LinkedIn followers
- 1,690
- Office locations
- 1
Percheron Therapeutics Limited company summary
Percheron Therapeutics Limited is a company in the Biotechnology Research industry, headquartered in Melbourne, Victoria, founded in 2000. On LinkedIn the company has around 9 employees and 1,690 followers.
What technology does Percheron Therapeutics Limited use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Percheron Therapeutics Limited
Percheron Therapeutics Limited (ASX: PER) is an international biotechnology company focused on the development of novel therapies for rare diseases. The company’s lead program is ATL1102, an antisense oligonucleotide targeting the CD49d receptor. ATL1102 is currently the subject of an ongoing international phase IIb clinical trial for the treatment of non-ambulant patients with Duchenne Muscular Dystrophy (DMD), for which data is expected in 2H CY2024. The drug has previously reported promising results from an exploratory phase IIa study in the same population and has been awarded orphan drug designation (ODD) and rare pediatric disease designation (RPDD) by the US FDA. For more information, please contact info@PercheronTx.com.
Where is Percheron Therapeutics Limited located?
Percheron Therapeutics Limited lists 1 location.
Compare companies similar to Percheron Therapeutics Limited
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Percheron Therapeutics Limited percherontx.com | Biotechnology Research | 9 | 2000 | Melbourne, Victoria |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Percheron Therapeutics Limited
What does Percheron Therapeutics Limited do?
Percheron Therapeutics Limited (ASX: PER) is an international biotechnology company focused on the development of novel therapies for rare diseases. The company’s lead program is ATL1102, an antisense oligonucleotide targeting the CD49d receptor. ATL1102 is currently the subject of an ongoing international phase IIb clinical trial for the treatment of non-ambulant patients with Duchenne Muscular Dystrophy (DMD), for which data is expected in 2H CY2024. The drug has previously reported promising results from an exploratory phase IIa study in the same population and has been awarded orphan drug designation (ODD) and rare pediatric disease designation (RPDD) by the US FDA. For more information, please contact info@PercheronTx.com.
How many employees does Percheron Therapeutics Limited have?
Percheron Therapeutics Limited has around 9 employees on LinkedIn.
Where is Percheron Therapeutics Limited headquartered?
Percheron Therapeutics Limited is headquartered in Melbourne, Victoria.
When was Percheron Therapeutics Limited founded?
Percheron Therapeutics Limited was founded in 2000.
Build a lead list from companies like Percheron Therapeutics Limited
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.